Dr Reddy's inks pact with Gilead to manufacture, market Remdesivir in India
Dr Reddy's would need to scale up manufacturing and obtain regulatory approval for marketing of this drug in respective countries, the company said
from Companies https://ift.tt/2YoVWgQ
from Companies https://ift.tt/2YoVWgQ
No comments: